IDEAYA Biosciences, Inc. (IDYA)
36.11
+0.05
(+0.14%)
USD |
NASDAQ |
Oct 09, 16:00
35.60
-0.51
(-1.41%)
After-Hours: 20:00
IDEAYA Biosciences Free Cash Flow (Quarterly) : -89.08M for June 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -89.08M |
| March 31, 2026 | -76.14M |
| December 31, 2025 | -90.83M |
| September 30, 2025 | 142.17M |
| June 30, 2025 | -63.14M |
| March 31, 2025 | -61.67M |
| December 31, 2024 | -122.76M |
| September 30, 2024 | -49.69M |
| June 30, 2024 | -33.86M |
| March 31, 2024 | -45.14M |
| December 31, 2023 | -24.59M |
| September 30, 2023 | -30.78M |
| June 30, 2023 | -34.34M |
| March 31, 2023 | -27.88M |
| December 31, 2022 | -23.37M |
| September 30, 2022 | -25.27M |
| June 30, 2022 | -21.93M |
| Date | Value |
|---|---|
| March 31, 2022 | -20.05M |
| December 31, 2021 | -17.26M |
| September 30, 2021 | -12.93M |
| June 30, 2021 | -13.51M |
| March 31, 2021 | -14.73M |
| December 31, 2020 | -11.78M |
| September 30, 2020 | 89.96M |
| June 30, 2020 | -13.68M |
| March 31, 2020 | -9.545M |
| December 31, 2019 | -8.922M |
| September 30, 2019 | -10.63M |
| June 30, 2019 | -10.72M |
| March 31, 2019 | -10.39M |
| December 31, 2018 | -7.785M |
| September 30, 2018 | -9.692M |
| June 30, 2018 | -6.108M |
| March 31, 2018 | -5.743M |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 58.28M |
| Xencor, Inc. | -56.20M |
| BioMarin Pharmaceutical, Inc. | 133.86M |
| MediciNova, Inc. | -1.92M |
| Viking Therapeutics, Inc. | -125.17M |